Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Boston ScientificBSX |
-$2.03B |
 |
MedtronicMDT |
-$93M |
 |
Edwards LifesciencesEW |
-$364M |
 |
Intuitive SurgicalISRG |
-$1.36B |
 |
GE HealthCareGEHC |
-$18M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Kline Kyle | Jan 8, 2026 | Sell | 3,594 | $101.1 | $360,000 |
| Norwalk Leslie V | Jan 8, 2026 | Sell | 2,000 | $101.1 | $200,000 |
| Norwalk Leslie V | Dec 12, 2025 | Sell | 4,000 | $88.85 | $360,000 |
| Kline Kyle | Dec 1, 2025 | Sell | 18,542 | $90 | $1.7M |
| Huller Kelly | Nov 25, 2025 | Sell | 7,500 | $90 | $680,000 |
| Davidar David D | Nov 12, 2025 | Sell | 25,000 | $86.0002 | $2.2M |
| ZARRILLI STEPHEN T | Nov 11, 2025 | Sell | 25,000 | $84.2903 | $2.1M |
| RHOADS ANN D | Nov 10, 2025 | Sell | 2,000 | $85 | $170,000 |
| RHOADS ANN D | Nov 7, 2025 | Sell | 8,000 | $81 | $650,000 |
| RHOADS ANN D | Sep 15, 2025 | Sell | 10,000 | $58.46 | $580,000 |
| RHOADS ANN D | Feb 28, 2025 | Sell | 7,500 | $78.68 | $590,000 |
| Pfeil Keith W | Jan 10, 2025 | Sell | 1,666 | $89.17 | $150,000 |
| Pfeil Keith W | Jan 10, 2025 | Sell | 12,501 | $88.17 | $1.1M |
| Huller Kelly | Dec 2, 2024 | Sell | 2,500 | $87.0006 | $220,000 |
| Davidar David D | Nov 22, 2024 | Sell | 6,766 | $85.0037 | $580,000 |
| Davidar David D | Nov 22, 2024 | Sell | 6,746 | $85.0037 | $570,000 |
| Lemaitre Dan | Nov 22, 2024 | Sell | 1,097 | $85.0166 | $93,000 |
| Lemaitre Dan | Nov 21, 2024 | Sell | 13,278 | $85 | $1.1M |
| Scavilla Daniel T | Nov 21, 2024 | Sell | 130,000 | $85 | $11M |
| Davidar David D | Nov 21, 2024 | Sell | 13,234 | $85 | $1.1M |
| Davidar David D | Nov 21, 2024 | Sell | 13,254 | $85 | $1.1M |
| Huller Kelly | Nov 6, 2024 | Sell | 2,500 | $82 | $210,000 |
| Scavilla Daniel T | Nov 6, 2024 | Sell | 60,000 | $80.02 | $4.8M |
| Huller Kelly | Oct 16, 2024 | Sell | 7,500 | $75.0199 | $560,000 |
| Davidar David D | Oct 16, 2024 | Sell | 30,000 | $75.0401 | $2.3M |
| Davidar David D | Oct 16, 2024 | Sell | 20,000 | $75.0305 | $1.5M |
| RHOADS ANN D | Sep 13, 2024 | Sell | 15,000 | $70.36 | $1.1M |
| Davidar David D | Sep 13, 2024 | Sell | 25,000 | $70.46 | $1.8M |
| Norwalk Leslie V | Jul 11, 2024 | Sell | 1,000 | $70 | $70,000 |
| Lemaitre Dan | May 10, 2024 | Sell | 63,300 | $64.6133 | $4.1M |
| Davidar David D | May 8, 2024 | Sell | 20,000 | $65 | $1.3M |
| Norwalk Leslie V | Mar 15, 2024 | Sell | 10,590 | $51.99 | $550,000 |
| Huller Kelly | Mar 1, 2024 | Sell | 3,115 | $54.53 | $170,000 |
| Huller Kelly | Mar 1, 2024 | Sell | 4,385 | $53.79 | $240,000 |
FAQ - Insider Transactions
The most recent insider transaction for Globus Medical was conducted by Kline Kyle, who sold 3,594 shares on January 8, 2026 at a price of $101.10 per share.
Scavilla Daniel T has sold the most GMED stock in the last 2 years, with a total value of $16M.
The total value of insider transactions for Globus Medical in the last 2 years is negative, amounting to -$45M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Globus Medical have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
